{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":23,"n_cols":5,"rows_kept":23,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[10,2,10,3],[11,2,11,3],[12,2,12,3],[13,2,13,3],[16,2,16,3],[17,2,17,3],[21,2,21,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910954143803321"]
[null,null,"Titolo",null,"Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academies Press, 2009"]
[null,null,"ISBN",null,"9786612083556"]
[{"$nulls":4},"9780309178167"]
[{"$nulls":4},"0309178169"]
[{"$nulls":4},"9781282083554"]
[{"$nulls":4},"1282083554"]
[{"$nulls":4},"9780309120890"]
[{"$nulls":4},"0309120896"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (149 p.)"]
[null,null,"Disciplina",null,"615/.19"]
[null,null,"Soggetti",null,"Orphan drugs - Government policy - United States"]
[{"$nulls":4},"Pharmaceutical policy - United States"]
[{"$nulls":4},"Drugs - Design - United States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 104-105)."]
[null,null,"Nota di contenuto",null,"Introduction and overview -- Current model for financing drug development : from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary."]
[null,null,null,"Sommario/riassunto","\"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled \"Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies.\" The purpose of the workshop was to explore innovative strategies for orphan drug development.\"--P. 3."]